Толщина эпикардиального жира в риск-стратификации больных ишемической болезнью сердца с кардиометаболическими нарушениями
At the moment Coronary artery disease (CAD) with cardiometabolic disorders and diabetes mellitus is one of the most common phenotypes of residual risk in cardiology. Epicardial fat thickness (EFT) attracts attention in the risk stratification of CAD as an important integral indicator of lipid metabolism disorders and insulin resistance. Background. To study the possibility of using epicardial fat thickness (EFT) as an additional non-invasive diagnostic criteria and risk stratification in patients with coronary artery disease and cardiometabolic disorders in uzbek population. Materials and methods. The study included 224 patients diagnosed with IHD, stable angina pectoris FC III and metabolic syndrome (IDF, 2005). The following were assessed: biochemical parameters and imaging markers, including EFT thickness, intima-media thickness, carotid artery stenosis. Results. During a 2-year follow-up, 87 patients who had undergone MCE (Group I) and 137 without (Group II) were identified. Group I had higher age (P < 0.05), diabetes mellitus rate (P < 0.05), coronary revascularization in anamnesis (P < 0.05). Significant differences in clinical and biochemical parameters, including a higher epicardial fat thickness (p < 0.01), were also identified. Based on the study results, a multiple logistic regression model was constructed using 4 significant variables - epicardial fat, age, Lp(a), and BMI. Conclusion. Epicardial fat thickness measured by echocardiography is an important prognostic factor in risk stratification of patients with coronary artery disease and cardiometabolic syndrome.
Сведения
- Журнал
- CARDIOLOGY OF UZBEKISTAN
- Опубликовано
- 2025 · Т. 1, № 2, С. 111-121
- Язык
- Русский
- ISSN
- 3060-4850
- Издатель
- Republican Specialized Scientific-Practical Medical Center of Cardiology